BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+22.78%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$12.2B
AUM Growth
+$12.2B
(+20%)
Cap. Flow
+$1.32B
Cap. Flow
% of AUM
10.82%
Top 10 Holdings %
Top 10 Hldgs %
86.71%
Holding
139
New
5
Increased
21
Reduced
9
Closed
18
Top Buys
| 1 |
Incyte
INCY
|
$1.42B |
| 2 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$14M |
| 3 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$10.9M |
| 4 |
Ascendis Pharma
ASND
|
$9.19M |
| 5 |
Neurogene
NGNE
|
$6.64M |
Top Sells
| 1 |
AbbVie
ABBV
|
$106M |
| 2 |
DSCI
Derma Sciences, Inc. Common Stock (DE)
DSCI
|
$19.5M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
$8.94M |
| 4 |
Exelixis
EXEL
|
$8.67M |
| 5 |
ARAV
Aravive, Inc. Common Stock
ARAV
|
$5.56M |
Sector Composition
| 1 | Healthcare | 92.13% |